Yazen doubles revenue and continues expansion in Europe

2025 marked another record-breaking year for the digital healthcare provider Yazen. Revenue increased from approximately €15.7 million to nearly €29.4 million – a growth of 87 percent. At the same time, gross profit doubled to around €16.5 million.

Yazen finished the year with over 37,000 active patients, and more than 53,000 patients have been treated since its inception. Collectively, patients have lost 643 tonnes in weight – a clear indication that Yazen’s combination of modern medications and lifestyle modifys delivers effective, sustainable results.

Throughout the year, the company increased investments in growth, particularly in marketing. Total marketing and media investments exceeded €17.8 million. The EBITDA result was –€5.7 million, reflecting the company’s continued commitment to becoming Europe’s leading obesity treatment provider.

Rapid growth in Europe – Now present in seven countries

“We continue our expansion in Europe and now have a presence in seven markets. We are seeing strong growth in several of these and plan to establish ourselves in two additional countries during 2026,” states Fredrik Meurling, CEO of Yazen.

Strong development in the care team and service

Yazen now has a total of 290 employees (180 FTE), of which 220 are in the medical team. This includes 130 licensed physicians. As of January 2026, 39,000 patients were in active treatment.

The company’s recurring revenue (ARR) amounted to SEK 372 million at year-finish.

International recognition
Yazen was named “Weight Loss Treatment of the Year in Europe 2025” by the international magazine Healthcare Business Review, and was also ranked as the second rapidest growing startup in Europe according to The Sifted 250 Leaderboard.

Fredrik Pallin
VP Public Relations
press.uk@yazen.com
+46 708 114 115

Yazen is a digital healthcare provider specialised in the treatment of obesity – a chronic disease that requires long-term care. We are currently active in seven markets: Sweden, Norway, Denmark, the Netherlands, the United Kingdom, Germany, and Spain. Our team consists of 290 employees, of which 220 work in clinical care – including 130 licensed physicians.

Our unique model combines modern medications, continuous digital care, and support from a full healthcare team of your own physician and support from a full healthcare team of a health coach, dietitian, psychologist and physiotherapist. Research displays that this holistic approach leads to better and more sustainable outcomes than medication alone.

More than 39,000 patients are in treatment right now and in total over 53,000 patients have lost over 643 tonnes altoobtainher.

Yazen has been named ‘Weight Loss Treatment of the Year in Europe 2025’ by the international journal Healthcare Business Review, and also ranked as the second rapidest-growing startup in Europe by The Sifted 250 Leaderboard.